{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:40:01Z","timestamp":1793724001515,"version":"4.6.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 111-2320-B-037-028"],"award-info":[{"award-number":["MOST 111-2320-B-037-028"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 111-2320-B-A49-036"],"award-info":[{"award-number":["MOST 111-2320-B-A49-036"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Colorectal cancer (CRC) is a highly prevalent cancer type with limited targeted therapies available and 5-year survival rate, particularly for late-stage patients. There have been numerous attempts to repurpose drugs to tackle this problem. It has been reported that autophagy inducers could augment the effect of certain chemotherapeutic agents by enhancing immunogenic cell death (ICD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we employed bioinformatics tools to identify thioridazine (THD), an antipsychotic drug, and found that it could induce autophagy and ICD in CRC. Then in vitro and in vivo experiments were performed to further elucidate the molecular mechanism of THD in CRC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>THD was found to induce endoplasmic reticulum (ER) stress in CRC cells by activating the eIF2\u03b1\/ATF4\/CHOP axis and facilitating the accumulation of secretory autophagosomes, leading to ICD. In addition, THD showed a remarkable ICD-activating effect when combined with oxaliplatin (OXA) to prevent tumor progression in the mouse model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Together, our findings suggest that the repurposed function of THD in inhibiting CRC involves the upregulation of autophagosomes and ER stress signals, promoting the release of ICD markers, and providing a potential candidate to enhance the clinical outcome for CRC treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12964-023-01190-5","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T05:02:26Z","timestamp":1690174946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Repurposing thioridazine for inducing immunogenic cell death in colorectal cancer via eIF2\u03b1\/ATF4\/CHOP and secretory autophagy pathways"],"prefix":"10.1186","volume":"21","author":[{"given":"Thu-Ha","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ren","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ying F.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,24]]},"reference":[{"issue":"1","key":"1190_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"1190_CR2","first-page":"1","volume-title":"Molecular biology of the cell. Sixth edition","author":"B Alberts","year":"2015","unstructured":"Alberts B. Molecular biology of the cell. Sixth edition. New York, NY: Garland Science, Taylor and Francis Group; 2015. p. 1."},{"issue":"1","key":"1190_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","volume":"22","author":"GP Dunn","year":"2004","unstructured":"Dunn GP, Old LJ, Schreiber RD. The Three Es of Cancer Immunoediting. Annu Rev Immunol. 2004;22(1):329\u201360.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"1190_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12(4):252\u201364.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"1190_CR5","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3390\/biom10050666","volume":"10","author":"E Koustas","year":"2020","unstructured":"Koustas E, Sarantis P, Papavassiliou AG, Karamouzis MV. The resistance mechanisms of checkpoint inhibitors in solid tumors. Biomolecules. 2020;10(5):666.","journal-title":"Biomolecules"},{"issue":"7","key":"1190_CR6","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/mc.23183","volume":"59","author":"H Ruan","year":"2020","unstructured":"Ruan H, Leibowitz BJ, Zhang L, Yu J. Immunogenic cell death in colon cancer prevention and therapy. Mol Carcinog. 2020;59(7):783\u201393.","journal-title":"Mol Carcinog"},{"key":"1190_CR7","doi-asserted-by":"crossref","unstructured":"Cohen R, Rousseau B, Vidal J, Colle R, Diazjr. LA, Andr\u00e9 T. Immune Checkpoint Inhibition in Colorectal Cancer: Microsatellite Instability and Beyond. Target Oncol. 2019. Available from: https:\/\/hal.sorbonne-universite.fr\/hal-02414292. [Cited 2022 Dec 17].","DOI":"10.1007\/s11523-019-00690-0"},{"issue":"4","key":"1190_CR8","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3390\/cancers12041047","volume":"12","author":"Z Asadzadeh","year":"2020","unstructured":"Asadzadeh Z, Safarzadeh E, Safaei S, Baradaran A, Mohammadi A, Hajiasgharzadeh K, et al. Current approaches for combination therapy of cancer: the role of immunogenic cell death. Cancers. 2020;12(4):1047.","journal-title":"Cancers"},{"issue":"1","key":"1190_CR9","doi-asserted-by":"publisher","first-page":"e000337","DOI":"10.1136\/jitc-2019-000337","volume":"8","author":"L Galluzzi","year":"2020","unstructured":"Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB, et al. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. J Immunother Cancer. 2020;8(1):e000337.","journal-title":"J Immunother Cancer"},{"issue":"9","key":"1190_CR10","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.3390\/cancers12092637","volume":"12","author":"JD Fumet","year":"2020","unstructured":"Fumet JD, Limagne E, Thibaudin M, Ghiringhelli F. Immunogenic cell death and elimination of immunosuppressive cells: a double-edged sword of chemotherapy. Cancers. 2020;12(9):2637.","journal-title":"Cancers"},{"issue":"8","key":"1190_CR11","doi-asserted-by":"publisher","first-page":"4854","DOI":"10.1111\/jcmm.14356","volume":"23","author":"J Zhou","year":"2019","unstructured":"Zhou J, Wang G, Chen Y, Wang H, Hua Y, Cai Z. Immunogenic cell death in cancer therapy: Present and emerging inducers. J Cell Mol Med. 2019;23(8):4854\u201365.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"1190_CR12","first-page":"1647","volume":"42","author":"F Li","year":"2019","unstructured":"Li F, Guo H, Yang Y, Feng M, Liu B, Ren X, et al. Autophagy modulation in bladder cancer development and treatment (Review). Oncol Rep. 2019;42(5):1647\u201355.","journal-title":"Oncol Rep"},{"issue":"8","key":"1190_CR13","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1158\/0008-5472.CAN-04-3640","volume":"65","author":"H Takeuchi","year":"2005","unstructured":"Takeuchi H, Kondo Y, Fujiwara K, Kanzawa T, Aoki H, Mills GB, et al. Synergistic Augmentation of Rapamycin-Induced Autophagy in Malignant Glioma Cells by Phosphatidylinositol 3-Kinase\/Protein Kinase B Inhibitors. Cancer Res. 2005;65(8):3336\u201346.","journal-title":"Cancer Res"},{"issue":"1","key":"1190_CR14","doi-asserted-by":"publisher","first-page":"e000462","DOI":"10.1136\/jitc-2019-000462","volume":"8","author":"Y Wang","year":"2020","unstructured":"Wang Y, Xie W, Humeau J, Chen G, Liu P, Pol J, et al. Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy. J Immunother Cancer. 2020;8(1):e000462.","journal-title":"J Immunother Cancer"},{"issue":"3","key":"1190_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41556-018-0042-2","volume":"20","author":"MD Rybstein","year":"2018","unstructured":"Rybstein MD, Bravo-San Pedro JM, Kroemer G, Galluzzi L. The autophagic network and cancer. Nat Cell Biol. 2018;20(3):243\u201351.","journal-title":"Nat Cell Biol"},{"issue":"12","key":"1190_CR16","doi-asserted-by":"publisher","first-page":"e966","DOI":"10.1038\/cddis.2013.493","volume":"4","author":"W Hou","year":"2013","unstructured":"Hou W, Zhang Q, Yan Z, Chen R, Zeh HJ III, Kang R, et al. Strange attractors: DAMPs and autophagy link tumor cell death and immunity. Cell Death Dis. 2013;4(12):e966\u2013e966.","journal-title":"Cell Death Dis"},{"issue":"5","key":"1190_CR17","doi-asserted-by":"publisher","first-page":"e1753","DOI":"10.1038\/cddis.2015.77","volume":"6","author":"HW Cheng","year":"2015","unstructured":"Cheng HW, Liang YH, Kuo YL, Chuu CP, Lin CY, Lee MH, et al. Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data. Cell Death Dis. 2015;6(5):e1753\u2013e1753.","journal-title":"Cell Death Dis"},{"issue":"3","key":"1190_CR18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/ijms20030473","volume":"20","author":"CW Chu","year":"2019","unstructured":"Chu CW, Ko HJ, Chou CH, Cheng TS, Cheng HW, Liang YH, et al. Thioridazine enhances P62-mediated autophagy and apoptosis through Wnt\/\u03b2-catenin signaling pathway in glioma cells. Int J Mol Sci. 2019;20(3):473.","journal-title":"Int J Mol Sci"},{"key":"1190_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/6709828","volume":"2016","author":"H Yue","year":"2016","unstructured":"Yue H, Huang D, Qin L, Zheng Z, Hua L, Wang G, et al. Targeting lung cancer stem cells with Antipsychological Drug Thioridazine. BioMed Res Int. 2016;2016:1\u20137.","journal-title":"BioMed Res Int"},{"issue":"2","key":"1190_CR20","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3892\/or.2016.5313","volume":"37","author":"C Zhang","year":"2017","unstructured":"Zhang C, Gong P, Liu P, Zhou N, Zhou Y, Wang Y. Thioridazine elicits potent antitumor effects in colorectal cancer stem cells. Oncol Rep. 2017;37(2):1168\u201374.","journal-title":"Oncol Rep"},{"issue":"4","key":"1190_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nrclinonc.2016.183","volume":"14","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi L, Bravo-San Pedro JM, Demaria S, Formenti SC, Kroemer G. Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy. Nat Rev Clin Oncol. 2017;14(4):247\u201358.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1190_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/cdd.2013.75","volume":"21","author":"I Martins","year":"2014","unstructured":"Martins I, Wang Y, Michaud M, Ma Y, Sukkurwala AQ, Shen S, et al. Molecular mechanisms of ATP secretion during immunogenic cell death. Cell Death Differ. 2014;21(1):79\u201391.","journal-title":"Cell Death Differ"},{"issue":"4","key":"1190_CR23","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/onc.2009.356","volume":"29","author":"A Tesniere","year":"2010","unstructured":"Tesniere A, Schlemmer F, Boige V, Kepp O, Martins I, Ghiringhelli F, et al. Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene. 2010;29(4):482\u201391.","journal-title":"Oncogene"},{"issue":"33","key":"1190_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.semcancer.2015.02.004","volume":"1","author":"O Kepp","year":"2015","unstructured":"Kepp O, Semeraro M, Bravo-San Pedro JM, Bloy N, Buqu\u00e9 A, Huang X, et al. eIF2\u03b1 phosphorylation as a biomarker of immunogenic cell death. Semin Cancer Biol. 2015;1(33):86\u201392.","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"1190_CR25","doi-asserted-by":"publisher","first-page":"1776570","DOI":"10.1080\/23723556.2020.1776570","volume":"7","author":"J Humeau","year":"2020","unstructured":"Humeau J, Bezu L, Kepp O, Kroemer G. EIF2\u03b1 phosphorylation: a hallmark of both autophagy and immunogenic cell death. Mol Cell Oncol. 2020;7(5):1776570.","journal-title":"Mol Cell Oncol"},{"issue":"23\u201324","key":"1190_CR26","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.drudis.2012.07.017","volume":"17","author":"XA Qu","year":"2012","unstructured":"Qu XA, Rajpal DK. Applications of Connectivity Map in drug discovery and development. Drug Discov Today. 2012;17(23\u201324):1289\u201398.","journal-title":"Drug Discov Today"},{"key":"1190_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.semcancer.2019.10.007","volume":"68","author":"V Shaw","year":"2021","unstructured":"Shaw V, Srivastava S, Srivastava SK. Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy. Semin Cancer Biol. 2021;68:75\u201383.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"1190_CR28","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.biomaterials.2013.10.049","volume":"35","author":"XY Ke","year":"2014","unstructured":"Ke XY, Lin Ng VW, Gao SJ, Tong YW, Hedrick JL, Yang YY. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells. Biomaterials. 2014;35(3):1096\u2013108.","journal-title":"Biomaterials"},{"issue":"9","key":"1190_CR29","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s10495-012-0717-2","volume":"17","author":"S Kang","year":"2012","unstructured":"Kang S, Dong SM, Kim BR, Park MS, Trink B, Byun HJ, et al. Thioridazine induces apoptosis by targeting the PI3K\/Akt\/mTOR pathway in cervical and endometrial cancer cells. Apoptosis. 2012;17(9):989\u201397.","journal-title":"Apoptosis"},{"issue":"10","key":"1190_CR30","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3390\/life12101477","volume":"12","author":"VWR Moraes","year":"2022","unstructured":"Moraes VWR, Santos VM, Suarez ER, Ferraz LS, Lopes R de M, Mognol GP, et al. argeting Ca2+ and Mitochondrial Homeostasis by Antipsychotic Thioridazine in Leukemia Cells. Life. 2022;12(10):1477.","journal-title":"Life"},{"issue":"11","key":"1190_CR31","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1080\/15548627.2015.1091141","volume":"11","author":"HO Rashid","year":"2015","unstructured":"Rashid HO, Yadav RK, Kim HR, Chae HJ. ER stress: Autophagy induction, inhibition and selection. Autophagy. 2015;11(11):1956\u201377.","journal-title":"Autophagy"},{"issue":"11","key":"1190_CR32","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/0028-3908(88)90006-8","volume":"27","author":"CN Svendsen","year":"1988","unstructured":"Svendsen CN, Froimowitz M, Hrbek C, Campbell A, Kula N, Baldessarini RJ, et al. Receptor affinity, neurochemistry and behavioral characteristics of the enantiomers of thioridazine: Evidence for different stereoselectivities at D1 and D2 receptors in rat brain. Neuropharmacology. 1988;27(11):1117\u201324.","journal-title":"Neuropharmacology"},{"issue":"106","key":"1190_CR33","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.biopha.2018.06.123","volume":"1","author":"M Seervi","year":"2018","unstructured":"Seervi M, Rani A, Sharma AK, Santhosh Kumar TR. ROS mediated ER stress induces Bax-Bak dependent and independent apoptosis in response to Thioridazine. Biomed Pharmacother. 2018;1(106):200\u20139.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"1190_CR34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4251\/wjgo.v6.i3.74","volume":"6","author":"CA Schonewolf","year":"2014","unstructured":"Schonewolf CA, Mehta M, Schiff D, Wu H, Haffty BG, Karantza V, et al. Autophagy inhibition by chloroquine sensitizes HT-29 colorectal cancer cells to concurrent chemoradiation. World J Gastrointest Oncol. 2014;6(3):74\u201382.","journal-title":"World J Gastrointest Oncol"},{"issue":"10","key":"1190_CR35","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1080\/15548627.2019.1596479","volume":"15","author":"J New","year":"2019","unstructured":"New J, Thomas SM. Autophagy-dependent secretion: mechanism, factors secreted, and disease implications. Autophagy. 2019;15(10):1682\u201393.","journal-title":"Autophagy"},{"key":"1190_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.oraloncology.2019.06.016","volume":"95","author":"SJ Park","year":"2019","unstructured":"Park SJ, Ye W, Xiao R, Silvin C, Padget M, Hodge JW, et al. Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer. Oral Oncol. 2019;95:127\u201335.","journal-title":"Oral Oncol"},{"issue":"12","key":"1190_CR37","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1158\/2326-6066.CIR-19-0228","volume":"7","author":"E Limagne","year":"2019","unstructured":"Limagne E, Thibaudin M, Nuttin L, Spill A, Derang\u00e8re V, Fumet JD, et al. Trifluridine\/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages. Cancer Immunol Res. 2019;7(12):1958\u201369.","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"1190_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41423-018-0026-y","volume":"16","author":"G Yu","year":"2019","unstructured":"Yu G, Wu Y, Wang W, Xu J, Lv X, Cao X, et al. Low-dose decitabine enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by re-modulating the tumor microenvironment. Cell Mol Immunol. 2019;16(4):401\u20139.","journal-title":"Cell Mol Immunol"},{"issue":"13","key":"1190_CR39","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1038\/emboj.2013.123","volume":"32","author":"KJ Petherick","year":"2013","unstructured":"Petherick KJ, Williams AC, Lane JD, Ord\u00f3\u00f1ez-Mor\u00e1n P, Huelsken J, Collard TJ, et al. Autolysosomal \u03b2-catenin degradation regulates Wnt-autophagy-p62 crosstalk. EMBO J. 2013;32(13):1903\u201316.","journal-title":"EMBO J"},{"issue":"6","key":"1190_CR40","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1158\/2159-8290.CD-17-1327","volume":"8","author":"CS Grasso","year":"2018","unstructured":"Grasso CS, Giannakis M, Wells DK, Hamada T, Mu XJ, Quist M, et al. Genetic Mechanisms of Immune Evasion in Colorectal Cancer. Cancer Discov. 2018;8(6):730\u201349.","journal-title":"Cancer Discov"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-023-01190-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-023-01190-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-023-01190-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T05:05:44Z","timestamp":1690175144000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-023-01190-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,24]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1190"],"URL":"https:\/\/doi.org\/10.1186\/s12964-023-01190-5","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,24]]},"assertion":[{"value":"31 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee at National Yang Ming Chiao Tung University and procedures were performed in accordance with the guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"184"}}